Dr. Jani highlighted the EMPIRE-1 trial, which evaluated the role of 18F-fluciclovine PET in guiding post-prostatectomy radiotherapy. The study demonstrated an improvement in 3-year freedom from ...
A total of 295 eligible patients were enrolled with a median follow-up of 5.0 years. The arms were well balanced, with a median age of 65 years (IQR 59-71), 50% with positive surgical margins, 51% ...
Short distance communication between computers has always been a hot topic. With various channels available to communicate in, we are always struggling to find the best combination of sending and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback